Clincosm LogoSign in Get a demo

healthy subject

Showing 1 - 25 of 66
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Subject Trial in Seoul (Neomazine Tab. 100mg, Myungin Chlorpromazine HCl Tab. 100mg)

Completed
  • Healthy Subject
  • Neomazine Tab. 100mg
  • Myungin Chlorpromazine HCl Tab. 100mg
  • Seoul, Korea, Republic of
    Whan In Pharm.
Nov 23, 2023

Healthy Subject Trial in Seongnam, Daejeon (CT-P41, US-licensed Prolia)

Completed
  • Healthy Subject
  • CT-P41
  • US-licensed Prolia
  • Seongnam, Bundang-gu, Korea, Republic of
  • +1 more
Sep 7, 2023

Healthy Subject Trial in Chengdu (GS3-007 oral liquid)

Not yet recruiting
  • Healthy Subject
  • GS3-007 oral liquid
  • Chengdu, Sichuan, China
    Chengdu Xinhua Hospital Affiliated to North Sichuan Medical Coll
Jun 16, 2023

Healthy Subject Trial in Seoul (Ursodeoxycholic Acid 250 Mg Oral Tablet)

Completed
  • Healthy Subject
  • Ursodeoxycholic Acid 250 Mg Oral Tablet
  • Seoul, Korea, Republic Of, Korea, Democratic People's Republic of
    Kyung Hee University Medical Hospital
Apr 16, 2023

Standardization of Test Methods and Evaluators for Testing of

Not yet recruiting
  • Healthy Subject
  • No drug will given
  • Gandhinagar, Gujarat, India
    NovoBliss Research Pvt Ltd
Mar 9, 2023

Healthy Subject Trial in Duarte (Behavioral Dietary Intervention, Educational Intervention, Exercise Intervention)

Active, not recruiting
  • Healthy Subject
  • Behavioral Dietary Intervention
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Jan 5, 2023

Healthy Subject Trial in Beijing (Orelabrutinib and (orelabrutinib tablet simulator), Orelabrutinib, Placebo (orelabrutinib

Active, not recruiting
  • Healthy Subject
  • Orelabrutinib and placebo (orelabrutinib tablet simulator)
  • +3 more
  • Beijing, China
    Beijing GoBroad Boren Hospital
Dec 19, 2022

Food Frequency Questionnaires in Estimating Food Nutrient Intake

Active, not recruiting
  • Healthy Subject
  • Questionnaire Administration
  • +2 more
  • Columbus, Ohio
    Arthur G. James Cancer Hospital and Solove Research Institute at
Dec 9, 2022

Healthy Subject Trial in Xingtai (STSA-1002 Injection, STSA-1005 Injection)

Recruiting
  • Healthy Subject
  • STSA-1002 Injection
  • STSA-1005 Injection
  • Xingtai, Hebei, China
    The Second Affiliated Hospital Of Xingtai Medical College
Nov 22, 2022

Healthy Subject Trial in Chengdu (GS3-007 oral liquid or Placebo GS3-007 oral liquid oral medication)

Recruiting
  • Healthy Subject
  • GS3-007 oral liquid or Placebo GS3-007 oral liquid oral medication
  • Chengdu, Chengdu, China
    Chengdu Xinhua Hospital Affiliated to North Sichuan Medical Coll
Nov 7, 2022

Healthy Subject Trial in Minneapolis, Columbus (Best Practice, Informational Intervention, Questionnaire Administration)

Active, not recruiting
  • Healthy Subject
  • Best Practice
  • +3 more
  • Minneapolis, Minnesota
  • +1 more
Sep 21, 2022

Healthy Subject Trial in Seattle (Dietary Fiber, Fish Oil, Placebo)

Completed
  • Healthy Subject
  • Dietary Fiber
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 8, 2022

Consumer Assessment of Tobacco Flavor and Odor

Recruiting
  • Current Vaper
  • Healthy Subject
  • Behavioral Intervention
  • Questionnaire Administration
  • Buffalo, New York
    Roswell Park Cancer Institute
Sep 7, 2022

Healthy Subject Trial in Beijing, Xingtai (STSA-1002 Injection, Placebo)

Not yet recruiting
  • Healthy Subject
  • STSA-1002 Injection
  • Placebo
  • Beijing, Beijing, China
  • +1 more
Aug 9, 2022

Healthy Subject Trial in Shanghai (3D229, Placebo)

Completed
  • Healthy Subject
  • Shanghai, Hongkou District, China
    Shanghai General hospital
Jun 20, 2022

Healthy Subject Trial in Fargo (SACT-1, EDURANT 25Mg Tablet)

Completed
  • Healthy Subject
  • Fargo, North Dakota
    Novum Pharmaceutical Research Services
May 22, 2022

Cutaneous Squamous Cell Carcinoma of the Head and Neck, Healthy Subject, Head Neck Cancer Trial in Houston (Biospecimen

Active, not recruiting
  • Cutaneous Squamous Cell Carcinoma of the Head and Neck
  • +2 more
  • Biospecimen Collection
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
May 11, 2022

Healthy Subject Trial in North York (ALS-4, Placebo)

Completed
  • Healthy Subject
  • North York, Ontario, Canada
    BioPharma Services Inc.
Apr 19, 2022

Healthy Subject, Pancreatic Carcinoma Trial in Palo Alto (diagnostic test, other, drug)

Active, not recruiting
  • Healthy Subject
  • Pancreatic Carcinoma
  • Computed Tomography
  • +3 more
  • Palo Alto, California
    Stanford University, School of Medicine
Apr 8, 2022

Healthy Subject Trial (HMPL-523)

Not yet recruiting
  • Healthy Subject
  • (no location specified)
Apr 1, 2022

Breast Carcinoma, Healthy Subject Trial in Buffalo (Photoacoustic Imaging)

Recruiting
  • Breast Carcinoma
  • Healthy Subject
  • Photoacoustic Imaging
  • Buffalo, New York
    Roswell Park Cancer Institute
Mar 25, 2022

Healthy Subject Trial in Groningen (Saline, ACT-246475, Rifampicin)

Completed
  • Healthy Subject
  • Groningen, Netherlands
    QPS Netherlands B.V.
Jan 18, 2022

Healthy Subject, Immunity Trial in Saint-Herblain (Botanical extract)

Recruiting
  • Healthy Subject
  • Immunity
  • Botanical extract
  • Saint-Herblain, France
    Biofortis Merieux Nutrisciences
Nov 23, 2021

Healthy Subject Trial in United States (Magnetic Resonance Imaging, Biospecimen Collection, Laboratory Biomarker Analysis)

Recruiting
  • Healthy Subject
  • Magnetic Resonance Imaging
  • +2 more
  • Duarte, California
  • +4 more
Nov 22, 2021

Myeloid Derived Suppressor Cells Clinical Assay in Finding

Recruiting
  • Healthy Subject
  • +5 more
  • Computed Tomography
  • +3 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Nov 16, 2021